| This monograph, sixth in the Current Issues series, draws upon the history and well-established safety record of PDE5 inhibitors; explores current clinical considerations, highlighting the role of daily dosing with PDE5 inhibitors; and examines future uses of the therapeutic class.
Please remember, in order to receive CME credit for this program you must download and complete the evaluation and posttest.
|